Europe Respiratory Care Devices Market is expected to reach US$ 11.88 billion by 2034 from US$ 6.22 billion in 2025, with a CAGR of 7.45% from 2026 to 2034. The Europe respiratory care devices market is expected to grow steadily during the forecast period, driven by rising respiratory disease prevalence, aging population, technological advancements, and increasing demand for home healthcare solutions.
Because chronic illnesses including COPD, asthma, sleep apnea, and acute respiratory infections are becoming more common, the European market for respiratory care devices is expanding rapidly. The need for cutting-edge, patient-friendly respiratory solutions is fueled by this, a move toward home healthcare, and continuous product innovation.
The European Federation of Allergy and Airways Diseases (2025) reported that over 36 million people in Europe had chronic obstructive lung disease, with a median frequency of 2,202 per 100,000 women and 3,230 per 100,000 males. Nebulizers, inhalers, ventilators, oxygen treatment systems, and portable monitoring devices are among the technologies that patients depend on to control their symptoms, avoid exacerbations, and carry out everyday tasks. As a result, the demand for these respiratory care devices is gradually rising due to the rising number of people with COPD, which is driving market expansion.
Furthermore, the European Respiratory Society (2024) reported that there were 27 million occurrences of asthma in Western Europe, with an estimated 12% of the UK population suffering from the illness. Inhalers, nebulizers, spacers, peak flow meters, and smart monitoring systems are among the tools that patients employ to manage airway inflammation, avoid unexpected asthma attacks, and keep an eye on lung function. The market for respiratory care devices is growing significantly due to the continuous requirement for these devices for both everyday maintenance and emergency treatment. Therefore, during the forecast period, all of the aforementioned reasons are anticipated to propel the European market for respiratory care devices.
As an illustration of the industry's move toward home-based, linked respiratory care solutions, ResMed announced improved digital features in its AirSenseTM line in March 2024, enabling patients to remotely track and optimize therapy.
The use of smart ventilators, CPAP devices, and portable oxygen concentrators is growing as healthcare systems prioritize lowering hospital readmission rates and enhancing patient outcomes. In homecare settings, these gadgets provide data integration, remote monitoring, and user-friendliness.
Healthcare providers have more control and patients have more comfort and autonomy while managing chronic respiratory illnesses thanks to the capacity to remotely monitor patients, modify therapy settings using applications, and integrate devices into larger digital health ecosystems.
Europe Respiratory Care Devices Industry Overview
The Europe respiratory care devices industry is a critical segment of the medical device sector, focused on diagnosing, monitoring, and treating respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and acute respiratory infections. The market includes a wide range of products such as ventilators, oxygen concentrators, nebulizers, CPAP and BiPAP devices, inhalers, and respiratory monitoring systems. Increasing prevalence of respiratory diseases across Europe, driven by factors such as air pollution, smoking, occupational hazards, and aging populations, is significantly boosting demand for advanced respiratory care solutions. Hospitals, clinics, emergency care centers, and home healthcare providers are increasingly relying on these devices to improve patient outcomes and reduce hospital admissions. Growing awareness regarding early diagnosis and long-term management of respiratory conditions is also contributing to market expansion.Because chronic illnesses including COPD, asthma, sleep apnea, and acute respiratory infections are becoming more common, the European market for respiratory care devices is expanding rapidly. The need for cutting-edge, patient-friendly respiratory solutions is fueled by this, a move toward home healthcare, and continuous product innovation.
The European Federation of Allergy and Airways Diseases (2025) reported that over 36 million people in Europe had chronic obstructive lung disease, with a median frequency of 2,202 per 100,000 women and 3,230 per 100,000 males. Nebulizers, inhalers, ventilators, oxygen treatment systems, and portable monitoring devices are among the technologies that patients depend on to control their symptoms, avoid exacerbations, and carry out everyday tasks. As a result, the demand for these respiratory care devices is gradually rising due to the rising number of people with COPD, which is driving market expansion.
Furthermore, the European Respiratory Society (2024) reported that there were 27 million occurrences of asthma in Western Europe, with an estimated 12% of the UK population suffering from the illness. Inhalers, nebulizers, spacers, peak flow meters, and smart monitoring systems are among the tools that patients employ to manage airway inflammation, avoid unexpected asthma attacks, and keep an eye on lung function. The market for respiratory care devices is growing significantly due to the continuous requirement for these devices for both everyday maintenance and emergency treatment. Therefore, during the forecast period, all of the aforementioned reasons are anticipated to propel the European market for respiratory care devices.
Growth Drivers for the Europe Respiratory Care Devices Market
Growing Demand as a Result of Increased Respiratory Conditions and Technological Developments in Homecare
One major factor driving the increase in demand for respiratory care equipment is the growing prevalence of chronic respiratory disorders like COPD, asthma, and sleep apnea, especially among Europe's aging population.As an illustration of the industry's move toward home-based, linked respiratory care solutions, ResMed announced improved digital features in its AirSenseTM line in March 2024, enabling patients to remotely track and optimize therapy.
The use of smart ventilators, CPAP devices, and portable oxygen concentrators is growing as healthcare systems prioritize lowering hospital readmission rates and enhancing patient outcomes. In homecare settings, these gadgets provide data integration, remote monitoring, and user-friendliness.
Healthcare providers have more control and patients have more comfort and autonomy while managing chronic respiratory illnesses thanks to the capacity to remotely monitor patients, modify therapy settings using applications, and integrate devices into larger digital health ecosystems.
Expansion of ICU and Emergency Care Infrastructure
Across Europe, continuous expansion and modernization of intensive care units (ICUs), emergency departments, and critical care facilities is significantly supporting demand for respiratory care devices. Hospitals are increasingly upgrading their critical care infrastructure to handle rising cases of respiratory failure, post-surgical complications, and infectious diseases. This has led to higher procurement of advanced ventilators, high-flow oxygen therapy systems, and multi-parameter respiratory monitoring devices. Governments and private healthcare providers are investing in ICU capacity expansion to improve preparedness for health emergencies and seasonal respiratory outbreaks. In addition, the integration of smart ICU systems and centralized patient monitoring platforms is enhancing respiratory support efficiency. As healthcare systems prioritize rapid response capabilities and critical care readiness, demand for advanced respiratory devices is expected to grow steadily across Europe.Increasing Burden of Air Pollution and Occupational Lung Diseases
Rising exposure to air pollution and workplace-related respiratory hazards is another key driver of the Europe respiratory care devices market. Urbanization, industrial emissions, and traffic pollution are contributing to higher incidence of chronic respiratory conditions, particularly in densely populated regions. Additionally, workers in industries such as mining, construction, manufacturing, and chemicals are at increased risk of occupational lung diseases, including pneumoconiosis and chronic bronchitis. These environmental and occupational health challenges are increasing reliance on respiratory diagnostic and therapeutic devices for early detection and long-term disease management. Healthcare providers are also emphasizing regular lung function screening and preventive respiratory care programs. As environmental health concerns continue to rise, demand for respiratory support systems and monitoring devices is expected to strengthen further.Challenges in the Europe Respiratory Care Devices Market
High Cost of Advanced Respiratory Devices
One of the key challenges in the Europe respiratory care devices market is the high cost associated with advanced medical equipment. Sophisticated devices such as ventilators, non-invasive respiratory support systems, and digital monitoring solutions require significant investment in research, development, and manufacturing. These high costs often translate into expensive end-user pricing, which can limit accessibility for smaller healthcare facilities and patients in lower-income regions. Although reimbursement policies exist in many European countries, coverage levels vary and may not fully offset device costs. In addition, ongoing maintenance, training, and software integration expenses further increase the total cost of ownership. This financial burden can slow down adoption rates, particularly in home healthcare settings. Managing affordability while maintaining technological innovation remains a key challenge for industry stakeholders across Europe.Strict Regulatory Requirements and Skilled Workforce Shortages
Stringent regulatory requirements and shortages of skilled healthcare professionals represent another major challenge for the Europe respiratory care devices market. Medical devices in Europe must comply with rigorous safety, performance, and quality standards, which can increase approval timelines and development costs for manufacturers. These regulatory complexities may delay product launches and limit market entry for smaller companies. In addition, the effective use of advanced respiratory care technologies requires skilled respiratory therapists, nurses, and healthcare professionals. However, many healthcare systems across Europe face workforce shortages, which can impact the quality of patient care and device utilization. Continuous training and education are required to ensure proper handling of advanced respiratory equipment. Addressing regulatory complexity and workforce constraints is essential for supporting sustainable market growth and improving patient outcomes across Europe.United Kingdom Respiratory Care Devices Market
The United Kingdom respiratory care devices market is growing steadily due to rising prevalence of chronic respiratory diseases, strong public healthcare infrastructure, and increasing adoption of home healthcare solutions. The National Health Service plays a key role in providing access to advanced respiratory therapies, including oxygen concentrators, ventilators, and inhalation devices. Increasing cases of asthma, COPD, and sleep apnea are driving demand for diagnostic and therapeutic respiratory equipment across hospitals and home care settings. The country is also witnessing growing adoption of digital health technologies and remote patient monitoring systems to improve disease management. In addition, government initiatives focused on reducing hospital admissions and improving chronic disease management are supporting market growth. Expansion of home-based care services and increasing awareness regarding early respiratory disease detection are expected to further strengthen the United Kingdom respiratory care devices market.Germany Respiratory Care Devices Market
The Germany respiratory care devices market is highly developed, supported by advanced healthcare infrastructure, strong medical technology innovation, and high prevalence of respiratory diseases. Hospitals and healthcare providers in Germany are increasingly adopting advanced ventilators, oxygen therapy systems, and digital respiratory monitoring devices to enhance patient care quality. The country has a strong focus on research and development in medical technologies, contributing to continuous innovation in respiratory care solutions. Rising cases of COPD, asthma, and sleep-related breathing disorders are increasing demand for long-term respiratory management solutions. In addition, Germany’s aging population is further contributing to market growth as elderly individuals are more susceptible to chronic respiratory conditions. Strong reimbursement systems and government healthcare support are also facilitating access to advanced respiratory devices. The German market is expected to continue expanding through technological advancements and increasing demand for home-based respiratory care.France Respiratory Care Devices Market
The France respiratory care devices market is expanding due to increasing respiratory disease prevalence, government healthcare support, and rising awareness of chronic disease management. Healthcare providers across France are adopting advanced respiratory devices to improve diagnosis, treatment, and monitoring of conditions such as asthma, COPD, and respiratory infections. The country is also investing in modern healthcare infrastructure and digital health technologies to enhance patient care efficiency. Growing demand for home healthcare solutions is encouraging the adoption of portable oxygen devices and non-invasive ventilation systems. In addition, public health initiatives focused on reducing smoking rates and improving air quality are indirectly supporting market growth. France’s strong healthcare system and increasing focus on preventive care are expected to drive continued expansion of the respiratory care devices market in the coming years.Italy Respiratory Care Devices Market
The Italy respiratory care devices market is witnessing steady growth driven by rising respiratory disease burden, improving healthcare infrastructure, and increasing adoption of home-based care solutions. Hospitals and clinics across Italy are increasingly using advanced respiratory devices such as ventilators, nebulizers, and oxygen therapy systems to manage chronic and acute respiratory conditions. The aging population in Italy is a major contributing factor, as elderly individuals are more prone to respiratory disorders. In addition, increasing healthcare expenditure and government support for healthcare modernization are improving access to advanced respiratory care technologies. The country is also experiencing growing demand for home healthcare services, supported by advancements in portable respiratory devices and remote monitoring systems. Continued focus on improving chronic disease management and expanding healthcare access is expected to support long-term growth of the Italy respiratory care devices market.Recent Developments in Europe Respiratory Care Devices Market
- Honeywell International Inc. successfully implemented the Bengaluru Safe City Project in March 2023 with the goal of improving urban safety using its cutting-edge security and respiratory care devices. This project highlights Honeywell's commitment to applying its knowledge of cutting-edge security systems by utilizing cutting-edge technologies to provide a more secure and resilient urban environment. The project contributes to the creation of safer, more intelligent cities by highlighting the growing importance of smart technology in urban safety.
- The Chesapeake Bay and Rivers Association of REALTORS (CBRAR) and Sentrilock, LLC, a top supplier of electronic lockbox solutions for the real estate sector, announced a strategic agreement in February 2023 to build a smart electronic lockbox marketplace for REALTOR members. In order to facilitate more effective and secure real estate transactions, this partnership aims to improve security and simplify accessibility for real estate professionals. The program demonstrates Sentrilock's dedication to fostering innovation and enhancing operational efficiency in the real estate industry.
Segmentation Analysis - Device Type, Indication, End-User
Application
- Chronic Obstructive Pulmonary Disease (COPD)
- Obstructive Sleep Apnea
- Asthma
- Respiratory Distress Syndrome
- Cystic Fibrosis
- Others
Device Type
- Therapeutic Devices
- Monitoring Devices
- Diagnostic Devices
- Consumables & Accessories
Product Type
- Respiratory Consumables
- Nebulizers
- Oxygen Concentrators
- Polysomnography Devices
- Pulse Oximeter
- Mechanical Ventilators
- Spirometers
- Others
End Users
- Hospitals
- Home Care
- Ambulatory Care
Countries
- France
- Germany
- Italy
- Spain
- United Kingdom
- Belgium
- Netherlands
- Russia
- Poland
- Greece
- Norway
- Romania
- Portugal
- Rest of Europe
All companies have been covered with 5 Viewpoints
- Overviews
- Key Person
- Recent Developments
- SWOT Analysis
- Revenue Analysis
Company Analysis:
- Medtronic Plc
- Koninklijke Philips
- General Electric Company
- Masimo Corporation
- ResMedInc
- Becton, Dickinson and Company
- Chart Industries Inc
- Getinge AB
Table of Contents
1. Introduction3. Executive Summary5. Europe Respiratory Care Devices Market14. Merger and Acquisition
2. Research & Methodology
4. Market Dynamics
6. Europe Respiratory Care Devices Market Share Analysis
7. Application - Historical and Current Market Trends & Forecast
8. Device Type - Historical and Current Market Trends & Forecast
9. Product Type - Historical and Current Market Trends & Forecast
10. End Users - Historical and Current Market Trends & Forecast
11. Countries - Historical and Current Market Trends & Forecast
12. Porter’s Five Forces Analysis
13. SWOT Analysis
15. Key Players Analysis
Companies Mentioned
- Medtronic Plc
- Koninklijke Philips
- General Electric Company
- Masimo Corporation
- ResMedInc
- Becton, Dickinson and Company
- Chart Industries Inc
- Getinge AB
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | June 2026 |
| Forecast Period | 2025 - 2034 |
| Estimated Market Value ( USD | $ 6.22 Billion |
| Forecasted Market Value ( USD | $ 11.88 Billion |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | Europe |
| No. of Companies Mentioned | 8 |
